Clinical Trials Browser

Phase 3 × Interventional × Adenocarcinoma of the Prostate × Clear all

NCT03686683 2024-10-08

ProVent

Phase 3 Completed

532 enrolled 14 charts

Adenocarcinoma of the Prostate

NCT03535675 2023-05-22

Muscadine Plus (MPX) In Men With Prostate Cancer

Phase 3 Terminated

59 enrolled 9 charts

Adenocarcinoma of the Prostate

NCT03327662 2021-01-06

CTC-STOP

Phase 3 Terminated

Adenocarcinoma of the Prostate